Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

Until Next Time

Nice to fill in for Doug Kass during a nice rally to close out a stellar first quarter for investors. The Dow posted its fourth up trading session in five this week. White House advisor Larry Kudlow comments today that the Fed Reserve should cut rat...

Seattle Genetics Struggles as Other Biotech Stocks Rise

Market is pretty much where it has been all day, nicely positive across the board. Biotech up nearly 2% on the day. Gilead Sciences, Inc. , and Celgene Corp. , are two large caps on the move for reasons we covered in previous posts. The Bristol-Myer...

Inverted Yield Curve Has Lost a Lot of Its Predictive Power

The market has given up some of its early gains, but the major indices are all still in the black. Homebuilders have given up their 1% rally early today and now are flat. The Atlanta Fed's GDPNow has the economy growing 1.7% now from the last readin...

A Solid Start for the Market

We are currently in process of restoring my access that is blocking me from seeing or commenting on the Daily Diary. We hope to have the problem resolved soon. Our apologies while getting the issue resolved. The market is off to a solid start this F...

Before the Open

Less than a hour to go before the market open as we await the last trading day of the first quarter. Pre-market futures are still pointing to a up opening. Gilead Sciences is up some 2% this morning after developmental partner Galapagos announced so...

How I Use Options to Mitigate Risk and Create Income

Buy-write strategies give you confidence to 'buy the dip' while also adding an extra income stream.

Last Trading Session of the Quarter: What's On Everyone's Mind?

It is good to be sitting in for Doug Kass on the Daily Diary this Friday morning. Hopefully we can end the trading week here together on a up note. Premarket futures look promising as global bourses rise on renewed optimism on the U.S./China trade t...

Future Brightens for 2 Small Biotech Stocks

The biotech sector isn't for the faint of heart, but these two companies issued promising news this week.

2 Recently Dinged Stocks Insiders Are Buying

A health and wellness provider and an amusement park operator have seen insider purchases amid declines in their shares.

Why I Make a Myriad of Small Biotech Bets

The fact is there are few more complex areas of the market than the small-cap biotech sector. Patience is key.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight